A Novel Hydrogen Sulfide Prodrug, <scp>SG</scp>1002, Promotes Hydrogen Sulfide and Nitric Oxide Bioavailability in Heart Failure Patients
Summary Recent studies demonstrate robust molecular cross talk and signaling between hydrogen sulfide (H 2 S) and nitric oxide ( NO ). Heart failure ( HF ) patients are deficient in both H 2 S and NO , two molecules that are critical for cardiovascular homeostasis. A phase I clinical trial of a nove...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | engleski |
| Izdano: |
2015
|
| Online pristup: | https://doi.org/10.1111/1755-5922.12128 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1755-5922.12128 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|